Initial Statement of Beneficial Ownership
2026-05-11SEC Filing 3 (0001213900-26-054429)
Jesper Hoeiland, a director at Allarity Therapeutics, Inc. (ALLR), filed an initial statement of beneficial ownership on May 11, 2026, reporting ownership as of June 10, 2025. The filing indicates that Mr. Hoeiland does not directly own any securities of the company. This statement is made in accordance with regulatory requirements for directors and significant owners.
Ticker mentioned:ALLR
Source:Original SEC Document β